Human Hepatocytes as a Tool for Studying Toxicity and Drug Metabolism
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Drugs are usually biotransformed into new chemical species that may have either toxic or therapeutic effects. Drug metabolism studies are routinely performed in laboratory animals but, due to metabolic interspecies differences when compared to man, they are not accurate enough to anticipate the metabolic profile of a drug in humans. Human hepatocytes in primary culture provide the closest in vitro model to human liver and the only model that can produce a metabolic profile of a given drug that is very similar to that found in vivo. However their availability is limited due to the restricted access to suitable tissue samples. The scarcity of human liver has led to optimising the cryopreservation of adult hepatocytes for long-term storage and regular supply. Human hepatocytes in primary culture express typical hepatic functions and express drug metabolising enzymes. Moreover, qualitative and quantitative similarities between in vitro and in vivo metabolism of drugs were observed. Different strategies have been envisaged to prolong cell survival and delay the spontaneous decay of the differentiated phenotype during culture. Thus, hepatocytes represent the most appropriate model for the evaluation of integrated drug metabolism, toxicity/metabolism correlations, mechanisms of hepatotoxicity, and the interactions (inhibition and induction) of xenobiotics and drug-metabolising enzymes. However, in view of limitations of primary hepatocytes, efforts are made to develop alternative cellular models (i.e. metabolic competent CYP-engineered cells stably expressing individual CYPs and transient expression of CYPs by transduction of hepatoma cells with recombinant adenoviruses). In summary, several cellular tools are available to address key issues at the earliest stages of drug development for a better candidate selection and hepatotoxicity risk assessment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, liverspecific functions of primary hepatocytes relevant for drug development and toxicity studies are rapidly downregulated during their in vitro cultures [57].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [57]
In the citing paper
“Immortalized cell lines can be used in most research instead of primary cells because they offer several advantages, including cost-effectiveness, ease of use, unlimited availability of materials, and the bypassing of ethical concerns associated with animal and human tissue use [14,15,16].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [14]
Citations
Cites
Progress in the reduction, refinement and replacement of animal experimentation
Balls, M., van Zeller, A.-M., & Halder, M. (2000) · DigitalGeorgetown (Georgetown University Library) · Cited by 296
Isolation, Culture and Use of Human Hepatocytes in Drug Research
Gómez-Lechón, M. J., Donato, M. T., Ponsoda, X., Fabra, R., Trullenque, R., & Castell, J. V. (1996) · Elsevier eBooks · doi:10.1016/b978-012163390-5.50007-7 · Cited by 53
Self-citation
Cited by
Organoid Models and Applications in Biomedical Research
Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · Nephron · doi:10.1159/000433566 · Cited by 3,515
THP-1 cell line: An in vitro cell model for immune modulation approach
Chanput, W., Mes, J. J., & Wichers, H. J. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.08.002 · Cited by 1,393
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citationRobust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice
Azuma, H., Paulk, N., Ranade, A., Dorrell, C., Al-Dhalimy, M., Ellis, E., Strom, S., Kay, M. A., Finegold, M., & Grompe, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1326 · Cited by 835
A liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Metadata
- Authors
- Gomez-Lechon, M., Donato, M., Castell, J., & Jover, R.
- Affiliations
- Hospital Universitari i Politècnic La Fe (ES)
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2003-08-01
- Volume
- 4
- Issue
- 4
- Pages
- 292-312
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W2112247582
- Cited by
- 242
- References
- 2
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 18 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 9 · 2016: 11 · 2015: 14 · 2014: 9 · 2013: 16 · 2012: 12
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- human hepatocytes, primary hepatocyte culture, drug metabolism, hepatotoxicity, toxicity prediction, drug-metabolizing enzymes, adenoviral transduction, hepatoma cells, xenobiotic interactions, in vitro-in vivo correlation, drug development
- MeSH terms
- Cells, Cultured, Cytochrome P-450 Enzyme System, Drug Interactions, Pharmaceutical Preparations, Humans, Liver, Models, Biological, Time Factors, Hepatocytes, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Hepatocytes as a Tool for Studying Toxicity and Drug Metabolism. https://app.cochat.ai/papers/10.2174/1389200033489424
- The paper
- Gomez-Lechon, M., Donato, M., Castell, J., & Jover, R. (2003). Human Hepatocytes as a Tool for Studying Toxicity and Drug Metabolism. Current Drug Metabolism. https://doi.org/10.2174/1389200033489424
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.